http://www.pharmalot.com/2007/08/glaxo-novartis-and-flu-vaccine-a-stupid-investment/ News, Comment and Conversation Fri, 10 Feb 2012 21:41:26 +0000 http://wordpress.org/?v=2.6.2 http://www.pharmalot.com/2007/08/glaxo-novartis-and-flu-vaccine-a-stupid-investment/#comment-17607 Pharma News 8_24 « Impactiviti blog Fri, 24 Aug 2007 11:35:57 +0000 http://www.pharmalot.com/2007/08/glaxo-novartis-and-flu-vaccine-a-stupid-investment/#comment-17607 [...] Glaxo and Novartis making stupid investments in vaccines? A 40-person company thinks [...] [...] Glaxo and Novartis making stupid investments in vaccines? A 40-person company thinks [...]

]]> http://www.pharmalot.com/2007/08/glaxo-novartis-and-flu-vaccine-a-stupid-investment/#comment-17603 George Fri, 24 Aug 2007 08:38:41 +0000 http://www.pharmalot.com/2007/08/glaxo-novartis-and-flu-vaccine-a-stupid-investment/#comment-17603 May drive AZ takeover by GSK? May drive AZ takeover by GSK?

]]> http://www.pharmalot.com/2007/08/glaxo-novartis-and-flu-vaccine-a-stupid-investment/#comment-17563 Slightly outside the box Thu, 23 Aug 2007 18:15:32 +0000 http://www.pharmalot.com/2007/08/glaxo-novartis-and-flu-vaccine-a-stupid-investment/#comment-17563 Well Novartis may not be so far off track. The Medimmune story today suggests that Novartis are pretty much aware of the need to use more modern technology. What about GSK? Also, can we assume that this means AZ don't have any intentions of using their newly acquired technology to develop their own vaccine business, or could they simply not get out of this deal (that must have been in the works for a while)? Either way, AZ are going to get benefits from vaccines and might, in the process, cause additional problems for GSK. Nice plan or just the way it worked out? Well Novartis may not be so far off track. The Medimmune story today suggests that Novartis are pretty much aware of the need to use more modern technology. What about GSK? Also, can we assume that this means AZ don’t have any intentions of using their newly acquired technology to develop their own vaccine business, or could they simply not get out of this deal (that must have been in the works for a while)? Either way, AZ are going to get benefits from vaccines and might, in the process, cause additional problems for GSK. Nice plan or just the way it worked out?

]]> http://www.pharmalot.com/2007/08/glaxo-novartis-and-flu-vaccine-a-stupid-investment/#comment-17558 VentureBeat » A biotech flu vaccine and the seduction of hype Thu, 23 Aug 2007 17:01:57 +0000 http://www.pharmalot.com/2007/08/glaxo-novartis-and-flu-vaccine-a-stupid-investment/#comment-17558 [...] developer Protein Sciences is all over the blogosphere today (see, for instance, items on Pharmalot and the WSJ health blog), thanks to a breathless Bloomberg piece on the little Meriden, Conn., [...] [...] developer Protein Sciences is all over the blogosphere today (see, for instance, items on Pharmalot and the WSJ health blog), thanks to a breathless Bloomberg piece on the little Meriden, Conn., [...]

]]>